Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Dependence on the CCR5 coreceptor for viral replication explains the lack of rebound of CXCR4-predicted HIV variants in the Berlin patient.

Symons J, Vandekerckhove L, Hütter G, Wensing AM, van Ham PM, Deeks SG, Nijhuis M.

Clin Infect Dis. 2014 Aug 15;59(4):596-600. doi: 10.1093/cid/ciu284.

2.

Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.

Cashin K, Jakobsen MR, Sterjovski J, Roche M, Ellett A, Flynn JK, Borm K, Gouillou M, Churchill MJ, Gorry PR.

Retrovirology. 2013 Sep 16;10:98. doi: 10.1186/1742-4690-10-98.

3.

Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.

Wilkin TJ, Goetz MB, Leduc R, Skowron G, Su Z, Chan ES, Heera J, Chapman D, Spritzler J, Reeves JD, Gulick RM, Coakley E.

Clin Infect Dis. 2011 Apr 1;52(7):925-8. doi: 10.1093/cid/cir072.

4.

Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.

Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P.

Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003.

PMID:
19446658
5.

Correlation of coreceptor usage and disease progression.

Verhofstede C, Nijhuis M, Vandekerckhove L.

Curr Opin HIV AIDS. 2012 Sep;7(5):432-9. doi: 10.1097/COH.0b013e328356f6f2. Review.

PMID:
22871636
6.

How HIV changes its tropism: evolution and adaptation?

Mosier DE.

Curr Opin HIV AIDS. 2009 Mar;4(2):125-30. doi: 10.1097/COH.0b013e3283223d61. Review.

7.
8.

Comparison of in vivo and in vitro evolution of CCR5 to CXCR4 coreceptor use of primary human immunodeficiency virus type 1 variants.

Edo-Matas D, van Dort KA, Setiawan LC, Schuitemaker H, Kootstra NA.

Virology. 2011 Apr 10;412(2):269-77. doi: 10.1016/j.virol.2011.01.010.

9.

High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.

Mild M, Gray RR, Kvist A, Lemey P, Goodenow MM, Fenyö EM, Albert J, Salemi M, Esbjörnsson J, Medstrand P.

Infect Genet Evol. 2013 Oct;19:369-77. doi: 10.1016/j.meegid.2013.05.004.

PMID:
23672855
10.

Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages.

Cashin K, Roche M, Sterjovski J, Ellett A, Gray LR, Cunningham AL, Ramsland PA, Churchill MJ, Gorry PR.

J Virol. 2011 Oct;85(20):10699-709. doi: 10.1128/JVI.05510-11.

11.

Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.

Utaipat U, Duerr A, Rudolph DL, Yang C, Butera ST, Lupo D, Pisell T, Tangmunkongvorakul A, Kamtorn N, Nantachit N, Nagachinta T, Suriyanon V, Robison V, Nelson KE, Sittisombut N, Lal RB.

AIDS Res Hum Retroviruses. 2002 Jan 1;18(1):1-11.

PMID:
11804551
12.

Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.

Glushakova S, Yi Y, Grivel JC, Singh A, Schols D, De Clercq E, Collman RG, Margolis L.

J Clin Invest. 1999 Sep;104(5):R7-R11.

13.

Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.

Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.

AIDS. 2008 Jul 31;22(12):1425-31. doi: 10.1097/QAD.0b013e32830184ba.

PMID:
18614865
14.

Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2.

Xiang SH, Pacheco B, Bowder D, Yuan W, Sodroski J.

Virology. 2013 Mar 30;438(1):5-13. doi: 10.1016/j.virol.2013.01.002.

15.

Appraising the performance of genotyping tools in the prediction of coreceptor tropism in HIV-1 subtype C viruses.

Crous S, Shrestha RK, Travers SA.

BMC Infect Dis. 2012 Sep 2;12:203. doi: 10.1186/1471-2334-12-203.

16.

Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.

Weber J, Vazquez AC, Winner D, Gibson RM, Rhea AM, Rose JD, Wylie D, Henry K, Wright A, King K, Archer J, Poveda E, Soriano V, Robertson DL, Olivo PD, Arts EJ, Quiñones-Mateu ME.

J Clin Microbiol. 2013 May;51(5):1517-27. doi: 10.1128/JCM.00092-13.

17.

Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.

Panos G, Watson DC.

Crit Rev Microbiol. 2015;41(4):473-87. doi: 10.3109/1040841X.2013.867829. Review.

PMID:
24635642
18.

HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.

Moncunill G, Armand-Ugón M, Pauls E, Clotet B, Esté JA.

AIDS. 2008 Jan 2;22(1):23-31.

PMID:
18090388
19.

Generation of a monkey-tropic human immunodeficiency virus type 1 carrying env from a CCR5-tropic subtype C clinical isolate.

Otsuki H, Yoneda M, Igarashi T, Miura T.

Virology. 2014 Jul;460-461:1-10. doi: 10.1016/j.virol.2014.04.037.

20.

Stable coreceptor usage of HIV in patients with ongoing treatment failure on HAART.

Lehmann C, Däumer M, Boussaad I, Sing T, Beerenwinkel N, Lengauer T, Schmeisser N, Wyen C, Fätkenheuer G, Kaiser R.

J Clin Virol. 2006 Dec;37(4):300-4.

PMID:
17005445
Items per page

Supplemental Content

Support Center